SlideShare une entreprise Scribd logo
1  sur  1
Télécharger pour lire hors ligne
Community-onset Clostridium difficile Infection                  a                                                 a                         b
                                              Dr Gracia Fellmeth , Dr Sucharita Yarlagadda , Dr Shabnam Iyer
                             a                                                                   b
                                 Specialty Registrar Public Health (Oxford Deanery); Consultant Microbiologist (Royal Berkshire Hospital)


Background                                                                                           Aims

Clostridium difficile infection (CDI) has traditionally been consid-                                 The aims of our study were to estimate the
ered a nosocomial infection, with established risk factors including:                                prevalence of community-onset CDI (CO-
                                                                                                     CDI) from diarrheal samples submitted
     age over 65 years                                                                              from a community setting, and to identify
     recent in-patient hospital or long-term care facility stay                                     risk factors for CDI in individuals previ-
     recent use of antimicrobials                                                                   ously considered to be at low risk.
     concomitant use of multiple antibiotics
     immunosuppression                                                                              Methods
     previous CDI
     underlying medical (especially gastro-intestinal) conditions.                                   A standard questionnaire was used to retrospectively obtain infor-
                                                                                                     mation on the CDI risk factors of 58 cases of CO-CDI diagnosed
Recently CDI has been increasingly observed in the community                                         between 1st April 2008 and 31st March 2009 in a community in the
setting and in individuals without established risk factors. Although                                South of England. Each case was reviewed for the presence of es-
reasons for this changing epidemiology are not fully understood,                                     tablished risk factors for CDI, i.e., age ≥ 65 years, in-patient hospi-
increasing host susceptibility due to novel risk factors, higher com-                                tal stay, and recent (within ≤ 4 weeks) receipt of broad spectrum
munity total antibiotic consumption, emergence of new epidemic C.                                    antibiotics, and other, ‘non-established’ risk factors for CDI, such
difficile strains, and a growing reservoir of asymptomatic carriers                                  as exposure to antibiotics more than 4 weeks preceding symptom
or colonised patients and animal reservoirs in the community are                                     onset, out-patient and day-surgery hospital exposure, contact with a
possible explanations.                                                                               hospitalised patient, and travel outside of the UK.

Results

                                                                         Fifty-eight cases of CO-CDI were diagnosed among a total community population of
                                                                         418,000, representing an estimated prevalence of CO-CDI of 1.29 per 10,000. All 58 cases
                                                                         were successfully contacted, representing a 100% response rate. Four cases were excluded
                                                                         from further analysis due to co-infection with Salmonella spp. and Campylobacter spp.

                                                                         Cases were more likely to be female, aged between 31 and 40 years, and present in the spring
                                                                         season (March to May), 2009 (Table 1). 46.3% (25/54) of cases had established risk factors
                                                                         for CDI, 20.4% (11/54) had non-established risk factors, 16.7% (9/54) had no risk factors and
                                                                         in the remaining 16.7% (9/54), available information was insufficient to classify by risk fac-
                                                                         tor category (Table 2 and Figure 1).

 Table 1: Summary of Case Characteristics

                            30
                                        25
                            25
          Number of Cases




                            20

                            15
                                                        11
                                                                         9            9
                            10

                            5

                            0
                                    Established   Non-Established       None       Unknown
                                                               Risk Factors
         Figure 1: Presence of Risk Factors among Cases of CO-CDI                                Table 2: Presence of Risk Factors among Cases of CO-CDI



Conclusions

Our study highlights some interesting issues. Recent receipt of antibiotics was the single most important risk factor for CO-CDI. How-
ever, overall less than half (46.3%) of all cases of CO-CDI were associated with established risk factors. Out-patient hospital exposure,
day-case surgical procedures, contact with recently hospitalised individuals, contact with known cases of CDI, and travel outside of the
UK were identified as non-established factors associated with developing CO-CDI. This suggests that CDI should be considered as a dif-
ferential diagnosis even in the absence of established risk factors. Larger and more systematic studies are needed to investigate these pos-
sible associations further, and to assess whether routine testing for CDI significantly affects case management.

Our study had a number of important limitations. Cases presenting to general practitioners represent only the minority of all cases in a
population, and reported cases might differ systematically (e.g. in severity) from unreported cases. The small total number of cases led to
greater uncertainty around estimate, and the significant (16.7%) proportion of questionnaires excluded due to insufficiency of information
added further uncertainty. The retrospective nature of the study raises the possibility of recall bias.

      Dr Gracia Fellmeth, Department of Public Health, Oxford University, Old Road Campus, Oxford OX3 8EQ. E-mail: gracia.fellmeth@nhs.net.

Contenu connexe

Tendances

mycelial forms of coccidiodes spp. in parasitic phase
mycelial forms of coccidiodes spp. in parasitic phasemycelial forms of coccidiodes spp. in parasitic phase
mycelial forms of coccidiodes spp. in parasitic phaseIPN
 
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...asclepiuspdfs
 
Efficacité de l'hydroxychloroquine et de l'azithromycine
Efficacité de l'hydroxychloroquine et de l'azithromycineEfficacité de l'hydroxychloroquine et de l'azithromycine
Efficacité de l'hydroxychloroquine et de l'azithromycineSociété Tripalio
 
Is susceptibility to tuberculosis acquired
Is susceptibility to tuberculosis acquiredIs susceptibility to tuberculosis acquired
Is susceptibility to tuberculosis acquiredThanka Elango
 
Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1
Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1
Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1Christian Wilhelm
 
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...Universidad Central de Venezuela
 
Undertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemicUndertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemicValentina Corona
 
Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...
Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...
Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...John Blue
 
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | SpartacusThe Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | SpartacusGuy Boulianne
 
Nosocomial Infections in Pediatric Intensive Care Unit
Nosocomial Infections in Pediatric Intensive Care UnitNosocomial Infections in Pediatric Intensive Care Unit
Nosocomial Infections in Pediatric Intensive Care Unitijtsrd
 
Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.
Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.
Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.Marios Stylianou
 
Final report
Final reportFinal report
Final reportSam Kirby
 
Covid-19 and Kidey Transplantation
Covid-19 and Kidey TransplantationCovid-19 and Kidey Transplantation
Covid-19 and Kidey TransplantationValentina Corona
 

Tendances (19)

mycelial forms of coccidiodes spp. in parasitic phase
mycelial forms of coccidiodes spp. in parasitic phasemycelial forms of coccidiodes spp. in parasitic phase
mycelial forms of coccidiodes spp. in parasitic phase
 
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
The Gibraltar COVID-19 Cohort: Determining the True Incidence and Severity Ra...
 
Efficacité de l'hydroxychloroquine et de l'azithromycine
Efficacité de l'hydroxychloroquine et de l'azithromycineEfficacité de l'hydroxychloroquine et de l'azithromycine
Efficacité de l'hydroxychloroquine et de l'azithromycine
 
Is susceptibility to tuberculosis acquired
Is susceptibility to tuberculosis acquiredIs susceptibility to tuberculosis acquired
Is susceptibility to tuberculosis acquired
 
Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1
Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1
Epidemiology treatment and_outcomes_of_sa_nosocomial_pneumonia_chest_2005-1
 
Dr Saurabh Kashyap
Dr Saurabh KashyapDr Saurabh Kashyap
Dr Saurabh Kashyap
 
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
NRAMP1 and VDR Gene Polymorphisms in Susceptibility to Tuberculosis in Venezu...
 
Undertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemicUndertstanding unreported cases in the 2019-nCov epidemic
Undertstanding unreported cases in the 2019-nCov epidemic
 
Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...
Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...
Dr. Kurt Stevenson - Antimicrobial Resistance Surveillance and Management in ...
 
Burn wound infections
Burn wound  infectionsBurn wound  infections
Burn wound infections
 
2008 co infecções de p. falciparum
2008 co infecções de p. falciparum2008 co infecções de p. falciparum
2008 co infecções de p. falciparum
 
Micosis pulmonar
Micosis pulmonarMicosis pulmonar
Micosis pulmonar
 
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | SpartacusThe Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
The Spartacus Letter – Rev. 2 (2021-09-28) | Spartacus
 
Nosocomial Infections in Pediatric Intensive Care Unit
Nosocomial Infections in Pediatric Intensive Care UnitNosocomial Infections in Pediatric Intensive Care Unit
Nosocomial Infections in Pediatric Intensive Care Unit
 
Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.
Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.
Marios Stylianou_Paper III_Antifungal application of nonantifungal drugs.
 
377 5587 Franchini 175
377 5587 Franchini 175377 5587 Franchini 175
377 5587 Franchini 175
 
Journal.pmed.1001843
Journal.pmed.1001843Journal.pmed.1001843
Journal.pmed.1001843
 
Final report
Final reportFinal report
Final report
 
Covid-19 and Kidey Transplantation
Covid-19 and Kidey TransplantationCovid-19 and Kidey Transplantation
Covid-19 and Kidey Transplantation
 

Similaire à Community onset C diff

Case control study.pdf
Case control study.pdfCase control study.pdf
Case control study.pdfDeput Putri
 
Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM
Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM
Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM Prashanth Manipadaga Lakshmi
 
Is Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitalsIs Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitalsCarl Aston
 
A review of the covid 19 pandemic and the role of medical laboratory scientis...
A review of the covid 19 pandemic and the role of medical laboratory scientis...A review of the covid 19 pandemic and the role of medical laboratory scientis...
A review of the covid 19 pandemic and the role of medical laboratory scientis...ArchanDomReyes
 
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...YogeshIJTSRD
 
Covid-19 and Bacillus Calmette-Guérin: what is the link?
Covid-19 and Bacillus Calmette-Guérin: what is the link?Covid-19 and Bacillus Calmette-Guérin: what is the link?
Covid-19 and Bacillus Calmette-Guérin: what is the link?Valentina Corona
 
Ms cs for_critically_ill_covid-19_patients.pdf
Ms cs for_critically_ill_covid-19_patients.pdfMs cs for_critically_ill_covid-19_patients.pdf
Ms cs for_critically_ill_covid-19_patients.pdfComprehensiveBiologi
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Arun Singh
 
A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...
A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...
A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...Holly M. Bevagna, MPH, BSc Micr., MLS(ASCP)
 
PScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2DPScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2DDat Tran, MD
 
Covid-19 Navigating the Uncharted
Covid-19 Navigating the UnchartedCovid-19 Navigating the Uncharted
Covid-19 Navigating the UnchartedValentina Corona
 
The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...Arete-Zoe, LLC
 
1. Basic Epidemiology.ppt
1. Basic Epidemiology.ppt1. Basic Epidemiology.ppt
1. Basic Epidemiology.pptNajmulHassan27
 
Coronavirus: medical management in a developed country that is china versus a...
Coronavirus: medical management in a developed country that is china versus a...Coronavirus: medical management in a developed country that is china versus a...
Coronavirus: medical management in a developed country that is china versus a...Vedica Sethi
 
abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)C M
 

Similaire à Community onset C diff (20)

Clostridium difficile 2010
Clostridium difficile 2010Clostridium difficile 2010
Clostridium difficile 2010
 
Case control study.pdf
Case control study.pdfCase control study.pdf
Case control study.pdf
 
Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM
Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM
Candida in icu and diagnosis DR M.L. PRASHANTH MD IDCCM
 
Is Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitalsIs Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitals
 
Candida Score-5.pptx
Candida Score-5.pptxCandida Score-5.pptx
Candida Score-5.pptx
 
Crypto 2010 guideline
Crypto 2010 guidelineCrypto 2010 guideline
Crypto 2010 guideline
 
Crypto 2010 guideline
Crypto 2010 guidelineCrypto 2010 guideline
Crypto 2010 guideline
 
A review of the covid 19 pandemic and the role of medical laboratory scientis...
A review of the covid 19 pandemic and the role of medical laboratory scientis...A review of the covid 19 pandemic and the role of medical laboratory scientis...
A review of the covid 19 pandemic and the role of medical laboratory scientis...
 
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
To Assess the Severity and Mortality among Covid 19 Patients after Having Vac...
 
Covid-19 and Bacillus Calmette-Guérin: what is the link?
Covid-19 and Bacillus Calmette-Guérin: what is the link?Covid-19 and Bacillus Calmette-Guérin: what is the link?
Covid-19 and Bacillus Calmette-Guérin: what is the link?
 
Ms cs for_critically_ill_covid-19_patients.pdf
Ms cs for_critically_ill_covid-19_patients.pdfMs cs for_critically_ill_covid-19_patients.pdf
Ms cs for_critically_ill_covid-19_patients.pdf
 
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
Corona virus disease-2019 (Covid-19 outbreak) epidemiology prevention and con...
 
A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...
A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...
A Public Health Intervention Strategy to Reduce the Incidence of Lyme disease...
 
PScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2DPScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2D
 
Covid-19 Navigating the Uncharted
Covid-19 Navigating the UnchartedCovid-19 Navigating the Uncharted
Covid-19 Navigating the Uncharted
 
Haemophylus ducreyi review
Haemophylus ducreyi reviewHaemophylus ducreyi review
Haemophylus ducreyi review
 
The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...The value of real-world evidence for clinicians and clinical researchers in t...
The value of real-world evidence for clinicians and clinical researchers in t...
 
1. Basic Epidemiology.ppt
1. Basic Epidemiology.ppt1. Basic Epidemiology.ppt
1. Basic Epidemiology.ppt
 
Coronavirus: medical management in a developed country that is china versus a...
Coronavirus: medical management in a developed country that is china versus a...Coronavirus: medical management in a developed country that is china versus a...
Coronavirus: medical management in a developed country that is china versus a...
 
abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)abbreviated C.diff COCA presentation (short)
abbreviated C.diff COCA presentation (short)
 

Plus de suchiey

Climate change and public health
Climate change and public healthClimate change and public health
Climate change and public healthsuchiey
 
Climate change and public health
Climate change and public healthClimate change and public health
Climate change and public healthsuchiey
 
Quality Improvement in HIV Clinics
Quality Improvement in HIV ClinicsQuality Improvement in HIV Clinics
Quality Improvement in HIV Clinicssuchiey
 
Stroke mortality and risk factors
Stroke mortality and risk factorsStroke mortality and risk factors
Stroke mortality and risk factorssuchiey
 
Provision of dental services to care homes
Provision of dental services to care homes Provision of dental services to care homes
Provision of dental services to care homes suchiey
 
Oxford Record Linkage Study
Oxford Record Linkage StudyOxford Record Linkage Study
Oxford Record Linkage Studysuchiey
 
Mercury poisoning
Mercury poisoningMercury poisoning
Mercury poisoningsuchiey
 
Provision of dental services to care homes
Provision of dental services to care homesProvision of dental services to care homes
Provision of dental services to care homessuchiey
 
Adult Obesity Peer Review Sep 2009
Adult Obesity Peer Review Sep 2009Adult Obesity Peer Review Sep 2009
Adult Obesity Peer Review Sep 2009suchiey
 
E. coli O157
E. coli O157 E. coli O157
E. coli O157 suchiey
 

Plus de suchiey (11)

Climate change and public health
Climate change and public healthClimate change and public health
Climate change and public health
 
Climate change and public health
Climate change and public healthClimate change and public health
Climate change and public health
 
Quality Improvement in HIV Clinics
Quality Improvement in HIV ClinicsQuality Improvement in HIV Clinics
Quality Improvement in HIV Clinics
 
Stroke mortality and risk factors
Stroke mortality and risk factorsStroke mortality and risk factors
Stroke mortality and risk factors
 
Provision of dental services to care homes
Provision of dental services to care homes Provision of dental services to care homes
Provision of dental services to care homes
 
Oxford Record Linkage Study
Oxford Record Linkage StudyOxford Record Linkage Study
Oxford Record Linkage Study
 
Mercury poisoning
Mercury poisoningMercury poisoning
Mercury poisoning
 
CSAS
CSASCSAS
CSAS
 
Provision of dental services to care homes
Provision of dental services to care homesProvision of dental services to care homes
Provision of dental services to care homes
 
Adult Obesity Peer Review Sep 2009
Adult Obesity Peer Review Sep 2009Adult Obesity Peer Review Sep 2009
Adult Obesity Peer Review Sep 2009
 
E. coli O157
E. coli O157 E. coli O157
E. coli O157
 

Community onset C diff

  • 1. Community-onset Clostridium difficile Infection a a b Dr Gracia Fellmeth , Dr Sucharita Yarlagadda , Dr Shabnam Iyer a b Specialty Registrar Public Health (Oxford Deanery); Consultant Microbiologist (Royal Berkshire Hospital) Background Aims Clostridium difficile infection (CDI) has traditionally been consid- The aims of our study were to estimate the ered a nosocomial infection, with established risk factors including: prevalence of community-onset CDI (CO- CDI) from diarrheal samples submitted  age over 65 years from a community setting, and to identify  recent in-patient hospital or long-term care facility stay risk factors for CDI in individuals previ-  recent use of antimicrobials ously considered to be at low risk.  concomitant use of multiple antibiotics  immunosuppression Methods  previous CDI  underlying medical (especially gastro-intestinal) conditions. A standard questionnaire was used to retrospectively obtain infor- mation on the CDI risk factors of 58 cases of CO-CDI diagnosed Recently CDI has been increasingly observed in the community between 1st April 2008 and 31st March 2009 in a community in the setting and in individuals without established risk factors. Although South of England. Each case was reviewed for the presence of es- reasons for this changing epidemiology are not fully understood, tablished risk factors for CDI, i.e., age ≥ 65 years, in-patient hospi- increasing host susceptibility due to novel risk factors, higher com- tal stay, and recent (within ≤ 4 weeks) receipt of broad spectrum munity total antibiotic consumption, emergence of new epidemic C. antibiotics, and other, ‘non-established’ risk factors for CDI, such difficile strains, and a growing reservoir of asymptomatic carriers as exposure to antibiotics more than 4 weeks preceding symptom or colonised patients and animal reservoirs in the community are onset, out-patient and day-surgery hospital exposure, contact with a possible explanations. hospitalised patient, and travel outside of the UK. Results Fifty-eight cases of CO-CDI were diagnosed among a total community population of 418,000, representing an estimated prevalence of CO-CDI of 1.29 per 10,000. All 58 cases were successfully contacted, representing a 100% response rate. Four cases were excluded from further analysis due to co-infection with Salmonella spp. and Campylobacter spp. Cases were more likely to be female, aged between 31 and 40 years, and present in the spring season (March to May), 2009 (Table 1). 46.3% (25/54) of cases had established risk factors for CDI, 20.4% (11/54) had non-established risk factors, 16.7% (9/54) had no risk factors and in the remaining 16.7% (9/54), available information was insufficient to classify by risk fac- tor category (Table 2 and Figure 1). Table 1: Summary of Case Characteristics 30 25 25 Number of Cases 20 15 11 9 9 10 5 0 Established Non-Established None Unknown Risk Factors Figure 1: Presence of Risk Factors among Cases of CO-CDI Table 2: Presence of Risk Factors among Cases of CO-CDI Conclusions Our study highlights some interesting issues. Recent receipt of antibiotics was the single most important risk factor for CO-CDI. How- ever, overall less than half (46.3%) of all cases of CO-CDI were associated with established risk factors. Out-patient hospital exposure, day-case surgical procedures, contact with recently hospitalised individuals, contact with known cases of CDI, and travel outside of the UK were identified as non-established factors associated with developing CO-CDI. This suggests that CDI should be considered as a dif- ferential diagnosis even in the absence of established risk factors. Larger and more systematic studies are needed to investigate these pos- sible associations further, and to assess whether routine testing for CDI significantly affects case management. Our study had a number of important limitations. Cases presenting to general practitioners represent only the minority of all cases in a population, and reported cases might differ systematically (e.g. in severity) from unreported cases. The small total number of cases led to greater uncertainty around estimate, and the significant (16.7%) proportion of questionnaires excluded due to insufficiency of information added further uncertainty. The retrospective nature of the study raises the possibility of recall bias. Dr Gracia Fellmeth, Department of Public Health, Oxford University, Old Road Campus, Oxford OX3 8EQ. E-mail: gracia.fellmeth@nhs.net.